Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

Nature Genetics

Volumn 44, Issue 12, 2012, Pages 1316-1320

  Richter, Julia ^a   Schlesner, Matthias ^b   Hoffmann, Steve ^c   Kreuz, Markus ^c   Leich, Ellen ^d   Burkhardt, Birgit ^e,f   Rosolowski, MacIej ^c   Ammerpohl, Ole ^a   Wagener, Rabea ^a   Bernhart, Stephan H ^c   Lenze, Dido ^g   Szczepanowski, Monika ^a   Paulsen, Maren ^a   Lipinski, Simone ^a   Russell, Robert B ^h   Adam Klages, Sabine ^a   Apic, Gordana ^h   Claviez, Alexander ⁱ   Hasenclever, Dirk ^c   Hovestadt, Volker ^b   Hornig, Nadine ^a   Korbel, Jan O ^j   Kube, Dieter ^k   Langenberger, David ^c   Lawerenz, Chris ^b   Lisfeld, Jasmin ^f   Meyer, Katharina ^l   Picelli, Simone ^b   Pischimarov, Jordan ^d   Radlwimmer, Bernhard ^b   Rausch, Tobias ^j   Rohde, Marius ^f   Schilhabel, Markus ^a   Scholtysik, René ^m   Spang, Rainer ^l   Trautmann, Heiko ⁱ   Zenz, Thorsten ^b,h,n   Borkhardt, Arndt ^o   Drexler, Hans G ^p   Möller, Peter ⁿ   MacLeod, Roderick A F ^p   Pott, Christiane ⁱ   Schreiber, Stefan ^a   Trümper, Lorenz ^k   Loeffler, Markus ^c   Stadler, Peter F ^c   Lichter, Peter ^b   Eils, Roland ^b,h   Küppers, Ralf ^m   Hummel, Michael ^g   Klapper, Wolfram ^a   Rosenstiel, Philip ^a   Rosenwald, Andreas ^d   Brors, Benedikt ^b   Siebert, Reiner ^a   more..

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f UNIVERSITY HOSPITAL GIESSEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^k UNIVERSITY OF GÖTTINGEN   (Germany)

^l UNIVERSITY OF REGENSBURG   (Germany)

^m UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁿ UNIVERSITY OF ULM   (Germany)

^o HEINRICH HEINE UNIVERSITY   (Germany)

^p Ulm University ^*  (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF DIFFERENTIATION 3; TRANSCRIPTOME;

ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; COHORT ANALYSIS; EXOME; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; GENE TRANSLOCATION; GENOME; HOMOZYGOSITY; IMMUNOGLOBULIN GENE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL;

BASE SEQUENCE; BURKITT LYMPHOMA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; FEMALE; GENES, IMMUNOGLOBULIN; GENES, MYC; GENOME, HUMAN; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; SEQUENCE ANALYSIS, DNA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSCRIPTOME; TRANSLOCATION, GENETIC;

EID: 84870544677     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2469     Document Type: Article

References (58)

1. Swerdlow, S.H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Ch. 10, 179-268 (IARC Press, Lyon, France, 2008).
2. Boerma, E.G., Siebert, R., Kluin, P.M. & Baudis, M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 23, 225-234 (2009).
3. Klapproth, K. & Wirth, T. Advances in the understanding of MYC-induced lymphomagenesis. Br. J. Haematol. 149, 484-497 (2010).
4. Scholtysik, R. et al. Detection of genomic aberrations in molecularly defined Burkitt′s lymphoma by array-based, high resolution, single nucleotide polymorphism analysis. Haematologica 95, 2047-2055 (2010).
5. Hummel, M. et al. A biologic definition of Burkitt′s lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354, 2419-2430 (2006). (Pubitemid 43855045)
6. Dave, S.S. et al. Molecular diagnosis of Burkitt′s lymphoma. N. Engl. J. Med. 354, 2431-2442 (2006).
7. Schmitz, R. et al. Recurrent oncogenic mutations in CCND3 in aggressive lymphomas. Blood (ASH Annual Meeting Abstracts) 118, 435 (2011).
8. Wilda, M. et al. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt′s lymphoma in children. Leukemia 18, 584-588 (2004). (Pubitemid 38425874)
9. Johnston, J.M. & Carroll, W.L. c-myc hypermutation in Burkitt′s lymphoma. Leuk. Lymphoma 8, 431-439 (1992).
10. Love, C.L. et al. Whole genome and exome sequencing reveals the genetic landscape of Burkitt lymphoma. Blood (ASH Annual Meeting Abstracts) 118, 433 (2011).
11. Duan, S. et al. FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas. Nature 481, 90-93 (2012).
12. Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497-2506 (2011).
13. Klapper, W. et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112, 1374-1381 (2008).
14. Klapper, W. et al. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma. Blood 119, 1882-1887 (2012).
15. Casellas, R. et al. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology 126, 316-328 (2009).
16. Salaverria, I. & Siebert, R. The gray zone between Burkitt′s lymphoma and diffuse large B-cell lymphoma from a genetics perspective. J. Clin. Oncol. 29, 1835-1843 (2011).
17. Perk, J., Iavaraone, A. & Benezra, R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 5, 603-614 (2005). (Pubitemid 41081386)
18. Kee, B.L. E and ID proteins branch out. Nat. Rev. Immunol. 9, 175-184 (2009).
19. Seitz, V. et al. Deep sequencing of MYC DNA-binding sites in Burkitt lymphoma. PLoS ONE 6, e26837 (2011).
20. Pan, L. et al. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell Biol. 19, 5969-5980 (1999). (Pubitemid 29399302)
21. Li, J. et al. Mutation of inhibitory helix-loop-helix protein Id3 causes γδ T-cell lymphoma in mice. Blood 116, 5615-5621 (2010).
22. Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116-120 (2012).
23. Sander, S. et al. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22, 167-179 (2012).
24. Dominguez-Sola, D. & Dalla-Favera, R. Burkitt lymphoma: much more than MYC. Cancer Cell 22, 141-142 (2012).
25. Medina, P.P. & Sanchez-Cespedes, M. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer. Epigenetics 3, 64-68 (2008).
26. Choi, Y.J. & Lee, S.G. The DEAD-box RNA helicase DDX3 interacts with DDX5, co-localizes with it in the cytoplasm during the G2/M phase of the cycle, and affects its shuttling during mRNP export. J. Cell Biochem. 113, 985-996 (2012).
27. Zenz, T. et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 112, 3322-3329 (2008).
28. van Dongen, J.J. et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257-2317 (2003).
29. Lefranc, M.P. et al. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 27, 209-212 (1999).
30. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
31. Lamprecht, B. et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat. Med. 16, 571-579 (2010).
32. Bibikova, M. et al. High density DNA methylation array with single CpG site resolution. Genomics 98, 288-295 (2011).
33. Hames, B.D. Gel Electrophoresis of Proteins, Vol. 3 (Oxford University Press, New York, 1998).
34. Lüschen, S. et al. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J. Biol. Chem. 275, 24670-24678 (2000). (Pubitemid 30626567)
35. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
36. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
37. Jones, D.T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100-105 (2012).
38. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
39. Quinlan, A.R. & Hall, I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
40. Ye, K., Schulz, M.H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865-2871 (2009).
41. Robinson, J.T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24-26 (2011).
42. Wang, J. et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat. Methods 8, 652-654 (2011).
43. Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333-i339 (2012).
44. Olshen, A.B. et al. Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. Bioinformatics 27, 2038-2046 (2011).
45. Boeva, V. et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423-425 (2012).
46. Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665-1674 (2007). (Pubitemid 350074862)
47. Rice, P., Longden, I. & Bleasby, A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 16, 276-277 (2000).
48. Ahmadpour, F. et al. Crystal structure of the minimalist Max-E47 protein chimera. PLoS ONE 7, e32136 (2012).
49. Sali, A. & Blundell, T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815 (1993). (Pubitemid 24007801)
50. Long, A., Guanga, G.P. & Rose, R.B. Crystal structure of E47-NeuroD1/β2 bHLH domain-DNA complex: heterodimer selectivity and DNA recognition. Biochemistry 47, 218-229 (2008).
51. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
52. Hoffmann, S. et al. Fast mapping of short sequences with mismatches, insertions and deletions using index structures. PLoS Comput. Biol. 5, e1000502 (2009).
53. Smyth, G.K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article 3 (2004).
54. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. A Stat. Soc. 57, 289-300 (1995).
55. Goeman, J.J., van de Geer, S.A., de Kort, F. & van Houwelingen, H.C. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20, 93-99 (2004). (Pubitemid 38088346)
56. Mansmann, U. & Meister, R. Testing differential gene expression in functional groups. Goeman′s global test versus an ANCOVA approach. Methods Inf. Med. 44, 449-453 (2005). (Pubitemid 41044345)
57. Läuter, J., Glimm, E. & Kropf, S. New tests for data with an inherent structure. Biometrical J. 38, 5-23 (1996). (Pubitemid 126394261)
58. Huber, W. et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96-S104 (2002). (Pubitemid 41185642)